Gold vs US Dollar

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NASDAQ
Gyre Therapeutics Inc (GYRE)
Gyre Therapeutics Inc (GYRE) Financials

GYRE Gyre Therapeutics Inc

11.72

-0.36 (-2.98%)

03 Jul 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-31.493	-65.75	-36.556	-49.382	-58.16	-116.848	-19.599	-128.198
Return on Equity (%)	-71.353	-108.921	-39.882	-58.612	-77.893	-150.11	-84.969	2401.37
Return on Invested Capital (%)	-86.433	-93.673	-45.082	-61.102	-81.331	-154.723	-254.067	-254.2
Operating Margin (%)	-4246.867	-2117.976	-500916.667	N/A	-268.479	-1198.324	-994.207	-67.84
Net Profit Margin (%)	-4246.867	-2506.09	-500916.667	N/A	-268.479	-1198.324	-1038.035	-81.915
Book Value Per Share	20.039	5.061	10.033	5.675	3.442	1.308	0.308	2.061
Earnings Per Share	-21.128	-4.195	-2.514	-4.583	-2.545	-2.8	-0.218	-2.447
Cash Per Share	12.798	2.38	2.611	1.276	1.374	1.412	0.574	0.882
Working Capital Per Share	19.397	4.994	9.97	5.578	3.245	1.188	0.301	0.979
Operating Profit Per Share	0.498	0.167	0.001	N/A	0.533	-0.001	N/A	2.893
EBIT Per Share	-21.128	-3.546	-2.514	-4.583	-2.545	-2.8	-0.209	-2.027
EBITDA Per Share	-21.128	-3.546	-2.514	-4.583	-2.545	-2.8	-0.209	-2.027
Free Cash Flow Per Share	-21.03	-4.22	-2.495	-4.589	-2.539	-2.809	-0.224	-2.249

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	1.708	4.475	25.826	3.324	5.03	3.634	1.677	2.854
Quick Ratio	1.665	4.325	25.034	3.179	4.645	3.436	1.585	2.428
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	13.773
Shares Outstanding	802k	6.08M	11.96M	12.04M	22.1M	31.41M	37.76M	N/A

Key Stats and Ratios

Year End 31 December 2023	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	N/A	N/A	37.76M	N/A	37.76M	37.98M	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	45.933
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	27.72
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	2.048	N/A	N/A	N/A	3.219
Quick Ratio	N/A	N/A	N/A	1.914	N/A	N/A	N/A	2.304
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	66.345

Key Stats and Ratios

Market Cap	1B
Price to Earnings Ratio	-10.78
Price to Sales Ratio	8.83
Price to Cash Ratio	29.91
Price to Book Ratio	12.77
Dividend Yield	-

Share Statistics

Shares Outstanding	85.51M
Average Volume (1 week)	70.31k
Average Volume (1 Month)	46.71k
52 Week Change	67.43%
52 Week High	30.40
52 Week Low	5.88

More Ratios Coming Soon!

Gyre Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions